[HTML][HTML] Small cell neuroendocrine carcinoma of the cervix: From molecular basis to therapeutic advances

A Chao, RC Wu, CY Lin, TC Chang, CH Lai - biomedical journal, 2023 - Elsevier
Small cell neuroendocrine carcinoma of the cervix (SCNECC) is an uncommon but
aggressive uterine malignancy, the cause of which is generally associated with human …

The anticancer effects of ferulic acid is associated with induction of cell cycle arrest and autophagy in cervical cancer cells

J Gao, H Yu, W Guo, Y Kong, lina Gu, Q Li… - Cancer Cell …, 2018 - Springer
Abstract Background Ferulic acid (4-hydroxy-3-methoxycinnamic acid, FA) is a
hydroxycinnamic acid derived from a rich polyphenolic compound. This study aimed to …

Current treatment strategies and future directions for extrapulmonary neuroendocrine carcinomas: a review

J Stelwagen, EGE de Vries, AME Walenkamp - JAMA oncology, 2021 - jamanetwork.com
Importance Patients with extrapulmonary neuroendocrine carcinomas (EPNECs) receive
essentially the same treatment as those with small cell lung cancer (SCLC) despite …

Expert Consensus Practice Recommendations of the North American Neuroendocrine Tumor Society for the management of high grade gastroenteropancreatic and …

JR Eads, TR Halfdanarson, T Asmis… - Endocrine-related …, 2023 - erc.bioscientifica.com
High-grade neuroendocrine neoplasms are a rare disease entity and account for
approximately 10% of all neuroendocrine neoplasms. Because of their rarity, there is an …

The prognosis of patients with small cell carcinoma of the cervix: a retrospective study of the SEER database and a Chinese multicentre registry

T Chu, Y Meng, P Wu, Z Li, H Wen, F Ren… - The Lancet …, 2023 - thelancet.com
Background Small cell carcinoma of the cervix is a rare but poor prognosis pathological type
of cervical cancer, for which advice in clinical guidelines is unspecific. We therefore aimed to …

Prognostic factors and optimal therapy for stages I–II neuroendocrine carcinomas of the uterine cervix: a multi-center retrospective study

M Ishikawa, T Kasamatsu, H Tsuda, M Fukunaga… - Gynecologic …, 2018 - Elsevier
Purpose We aimed to determine appropriate treatment guidelines for patients with stages I–
II high-grade neuroendocrine carcinomas (HGNEC) of the uterine cervix in a multicenter …

Recent advances in the management of small cell carcinoma of the uterine cervix

AI Miyoshi, Y Ueda, T Kurita, T Kimura… - Anticancer …, 2023 - ar.iiarjournals.org
Background/Aim: Small cell neuroendocrine carcinoma of the cervix (SCNEC) is a rare
disease characterized by a higher incidence of lymphatic invasion, metastasis, and …

Cycles of cisplatin and etoposide affect treatment outcomes in patients with FIGO stage I-II small cell neuroendocrine carcinoma of the cervix

X Pei, L Xiang, S Ye, T He, Y Cheng, W Yang, X Wu… - Gynecologic …, 2017 - Elsevier
Objective This study sought to explore the outcomes and prognostic factors of patients with
small cell neuroendocrine carcinoma of the cervix (SCNEC) and to determine the effects of …

The prognostic impact of the immune microenvironment in small-cell neuroendocrine carcinoma of the uterine cervix: PD-L1 and immune cell subtypes

X Sun, L Liu, T Wan, Q Huang, J Chen, R Luo… - Cancer Cell …, 2022 - Springer
Background We investigate the correlation between programmed cell death-ligand 1 (PD-
L1) and tumor-associated immune cell (TAIC) density in small-cell neuroendocrine …

The role of postoperative radiation after radical hysterectomy for women with early-stage neuroendocrine carcinoma of the cervix: A meta-analysis

C Kim, G Salvo, M Ishikawa, TC Chen, A Jhingran… - Gynecologic …, 2023 - Elsevier
Introduction Neuroendocrine carcinoma of the cervix (NECC) is an aggressive disease with
high rates of nodal disease spread even in seemingly cervix-confined disease. Many …